DME (psychedelic)

DME (psychedelic)
Names


IUPAC name 2-Amino-1-(3,4-dimethoxy-phenyl)-ethanol
Other names 3,4-Dimethoxy-beta-hydroxyphenethylamine 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
CAS Number	6924-15-8^Y
3D model (Jmol)	Interactive image Interactive image
ChemSpider	3088871^Y
PubChem	3863978
InChI InChI=1S/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3^Y Key: WIUFFBGZBFVVDL-UHFFFAOYSA-N^Y InChI=1/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYAL
SMILES COc1cc(ccc1OC)C(O)CN O(c1ccc(cc1OC)C(O)CN)C
Properties
Chemical formula	C₁₀H₁₅NO₃
Molar mass	197.23 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is ^YN ?)
Infobox references

DME, or 3,4-dimethoxy-beta-hydroxy phenethylamine, is a lesser-known psychedelic drug. It is the beta-hydroxy analog of DMA. DME was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.

External links

Drugs from PiHKAL

This article is issued from Wikipedia - version of the 7/7/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.